Azenta share price today

(AZTA)

Azenta share price is $45.91 & -₹45.91 as on 12 Dec 2024, 2.30 'hrs' IST

$45.91

▲

-0.45

(-0.97%)

Market is closed - opens 8 PM, 12 Dec 2024

View live Azenta share price in Dollar and Rupees. Guide to invest in Azenta from India. Also see the sentimental analysis on Indian investors investing in Azenta. Get details on the Indian mutual funds that are investing in Azenta. Get Analyst recommendations and forecasts along with all the Azenta's financials.

Azenta share price movements

$45.72
$46.75
$45.91
0.42%
Downside
Day's Volatility :2.21%
Upside
1.8%
$38.82
$69.16
$45.91
15.44%
Downside
52 Weeks Volatility :43.87%
Upside
33.62%

Azenta Returns

Period	Azenta Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-2.15%	-8.8%	0.0%
6 Months	-16.16%	-2.7%	0.0%
1 Year	-24.07%	6.5%	0.0%
3 Years	-54.32%	5.6%	-20.0%

Azenta Key Statistics

in dollars & INR

Previous Close	$46.36
Open	$46.52
Today's High	$46.75
Today's Low	$45.715
Market Capitalization	$2.1B
Today's Volume	$320.5K
52 Week High	$69.16
52 Week Low	$38.82
Revenue TTM	$656.3M
EBITDA	$20.3M
Earnings Per Share (EPS)	$-3.09
Profit Margin	-25.01%
Quarterly Earnings Growth YOY	87.78%
Return On Equity TTM	-7.63%

How to invest in Azenta from India?

It is very easy for Indian residents to invest directly in Azenta from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Azenta stock in both rupees (INR) and dollars (USD). Search for Azenta or AZTA on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Azenta or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Azenta shares which would translate to -0.000 fractional shares of Azenta as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Azenta

300%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Search volume for Azenta on INDmoney from India has grown in the last 30 days as on Dec 12, 2024. 300% more investors are searching Azenta in the last 30 days versus the previous period.

Global Institutional Holdings in Azenta

BlackRock Inc
10.56%
Vanguard Group Inc
10.26%
Politan Capital Management LP
10.12%
Dimensional Fund Advisors, Inc.
6.60%
Kayne Anderson Rudnick Investment Management LLC
5.00%
State Street Corp
3.70%

Analyst Recommendation on Azenta

Buy

53%Buy

46%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Azenta(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Azenta

What analysts predicted

Upside of 23.28%

Current:

$45.91

Target:

$56.60

Insights on Azenta

Price Movement
In the last 7 days, AZTA stock has moved up by 2.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 172.80M → 170.06M (in $), with an average decrease of 1.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -136.88M → -4.98M (in $), with an average increase of 1005.8% per quarter
AZTA vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 69.5% return, outperforming this stock by 91.2%
AZTA vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 57.6% return, outperforming this stock by 112.8%
Price to Sales
ForAZTA every $1 of sales, investors are willing to pay $3.7, whereas for Intuitive Surgical, Inc., the investors are paying $24.5 for every $1 of sales.

Azenta Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$781.9M	↑ 23.8%
Net Income	$9.9M	↓ 91.52%
Net Profit Margin	1.26%	↓ 17.2%

	FY20	Y/Y Change
Revenue	$897.3M	↑ 14.76%
Net Income	$64.9M	↑ 555.74%
Net Profit Margin	7.23%	↑ 5.97%

	FY21	Y/Y Change
Revenue	$513.7M	↓ 42.75%
Net Income	$-28.9M	↓ 144.51%
Net Profit Margin	-5.62%	↓ 12.85%

	FY22	Y/Y Change
Revenue	$555.5M	↑ 8.14%
Net Income	$-11.3M	↓ 60.91%
Net Profit Margin	-2.03%	↑ 3.59%

	FY23	Y/Y Change
Revenue	$665.1M	↑ 19.73%
Net Income	$-14.3M	↑ 26.32%
Net Profit Margin	-2.14%	↓ 0.11%

	FY24	Y/Y Change
Revenue	$656.3M	↓ 1.32%
Net Income	$-164.2M	↑ 1051.5%
Net Profit Margin	-25.01%	↓ 22.87%

	Q2 FY23	Q/Q Change
Revenue	$165.9M	↑ 11.82%
Net Income	$-1.5M	↓ 26.17%
Net Profit Margin	-0.89%	↑ 0.45%

	Q3 FY23	Q/Q Change
Revenue	$172.4M	↑ 3.86%
Net Income	$3.4M	↓ 329.59%
Net Profit Margin	1.96%	↑ 2.85%

	Q4 FY23	Q/Q Change
Revenue	$154.3M	↓ 10.47%
Net Income	$-15.7M	↓ 565.9%
Net Profit Margin	-10.19%	↓ 12.15%

	Q1 FY24	Q/Q Change
Revenue	$159.1M	↑ 3.12%
Net Income	$-136.9M	↑ 770.52%
Net Profit Margin	-86.02%	↓ 75.83%

	Q2 FY24	Q/Q Change
Revenue	$172.8M	↑ 8.59%
Net Income	$-6.6M	↓ 95.19%
Net Profit Margin	-3.81%	↑ 82.21%

	Q3 FY24	Q/Q Change
Revenue	$170.1M	↓ 1.59%
Net Income	$-5.0M	↓ 24.28%
Net Profit Margin	-2.93%	↑ 0.88%

	FY19	Y/Y Change
Total Assets	$1.5B	↑ 38.42%
Total Liabilities	$377.8M	↓ 0.11%

	FY20	Y/Y Change
Total Assets	$1.6B	↑ 2.77%
Total Liabilities	$345.5M	↓ 8.54%

	FY21	Y/Y Change
Total Assets	$1.8B	↑ 16.7%
Total Liabilities	$494.2M	↑ 43.03%

	FY22	Y/Y Change
Total Assets	$3.7B	↑ 104.24%
Total Liabilities	$352.7M	↓ 28.62%

	FY23	Y/Y Change
Total Assets	$2.9B	↓ 22.35%
Total Liabilities	$351.2M	↓ 0.43%

	FY24	Y/Y Change
Total Assets	$2.1B	↓ 27.23%
Total Liabilities	$331.1M	↓ 5.74%

	Q2 FY23	Q/Q Change
Total Assets	$3.1B	↓ 5.55%
Total Liabilities	$345.9M	↓ 2.45%

	Q3 FY23	Q/Q Change
Total Assets	$2.9B	↓ 5.98%
Total Liabilities	$351.2M	↑ 1.53%

	Q4 FY23	Q/Q Change
Total Assets	$2.8B	↓ 2.13%
Total Liabilities	$380.7M	↑ 8.38%

	Q1 FY24	Q/Q Change
Total Assets	$2.6B	↓ 9.23%
Total Liabilities	$340.6M	↓ 10.51%

	Q2 FY24	Q/Q Change
Total Assets	$2.3B	↓ 9.37%
Total Liabilities	$332.9M	↓ 2.27%

	Q3 FY24	Q/Q Change
Total Assets	$2.1B	↓ 9.61%
Total Liabilities	$331.1M	↓ 0.55%

	FY19	Y/Y Change
Operating Cash Flow	$90.9M	↑ 22.89%
Investing Cash Flow	$211.3M	↓ 242.33%
Financing Cash Flow	$-191.2M	↓ 212.26%

	FY20	Y/Y Change
Operating Cash Flow	$37.9M	↓ 58.34%
Investing Cash Flow	$-22.7M	↓ 110.76%
Financing Cash Flow	$-27.0M	↓ 85.86%

	FY21	Y/Y Change
Operating Cash Flow	$149.9M	↑ 295.76%
Investing Cash Flow	$-146.3M	↑ 543.52%
Financing Cash Flow	$-25.9M	↓ 4.13%

	FY22	Y/Y Change
Operating Cash Flow	$-466.0M	↓ 410.99%
Investing Cash Flow	$1.5B	↓ 1101.43%
Financing Cash Flow	$-62.8M	↑ 142.27%

	FY23	Y/Y Change
Operating Cash Flow	$17.5M	↓ 103.75%
Investing Cash Flow	$431.4M	↓ 70.57%
Financing Cash Flow	$-844.1M	↑ 1244.89%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$16.7M	↓ 237.84%
Investing Cash Flow	$214.4M	↑ 268.49%
Financing Cash Flow	$-172.1M	↑ 41266.59%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$39.9M	↑ 138.31%
Investing Cash Flow	$102.5M	↓ 52.19%
Financing Cash Flow	$-166.9M	↓ 3.04%

Azenta Technicals Summary

Sell

Neutral

Buy

Azenta is currently in a neutral trading position according to technical analysis indicators.

Azenta Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Azenta Inc	-0.17%	-16.16%	-24.07%	-54.32%	-54.12%
Intuitive Surgical, Inc.	1.22%	28.54%	65.25%	59.71%	176.39%
Resmed Inc.	-0.58%	15.73%	42.81%	-6.72%	57.55%
Becton, Dickinson And Company	-4.42%	-4.71%	-8.08%	-12.57%	-18.1%
West Pharmaceutical Services Inc	-2.89%	-5.37%	-11.53%	-27.83%	116.11%
Alcon Ag	-0.37%	-5.23%	15.35%	3.59%	53.9%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Azenta Inc	1.57	NA	NA	0.33	-0.08	-0.02	NA	38.82
Intuitive Surgical, Inc.	87.76	87.76	4.06	6.84	0.16	0.08	NA	43.75
Resmed Inc.	32.57	32.57	1.86	7.71	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	37.72	37.72	1.02	13.11	0.06	0.03	0.02	89.47
West Pharmaceutical Services Inc	47.14	47.14	5.94	6.66	0.18	0.1	0.0	37.96
Alcon Ag	36.67	36.67	3.1	3.03	0.06	0.03	0.0	43.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Azenta Inc	Buy	$2.1B	-54.12%	1.57	-25.01%
Intuitive Surgical, Inc.	Buy	$195.9B	176.39%	87.76	28.51%
Resmed Inc.	Buy	$36.0B	57.55%	32.57	23.15%
Becton, Dickinson And Company	Buy	$64.0B	-18.1%	37.72	7.13%
West Pharmaceutical Services Inc	Buy	$23.0B	116.11%	47.14	17.37%
Alcon Ag	Buy	$42.7B	53.9%	36.67	11.89%

Azenta Dividend announcements

Azenta Dividends December, 2021
In the quarter ending December,2021. Azenta has declared dividend of $0.10
Read More

About Azenta

azenta (nasdaq: azta) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. azenta is headquartered in chelmsford, ma, with operations in north america, europe and asia. for more information, please visit www.azenta.com.

Organization	Azenta
Employees	0
CEO	Mr. Jason W. Joseph J.D.
Industry	Technology

Management People of Azenta

Name	Title
Mr. Jason W. Joseph J.D.	Senior VP, General Counsel & Corporate Secretary
Mr. John P. Marotta	President, CEO & Director
Mr. Lawrence Y. Lin	Executive VP & CFO
Ms. Violetta Hughes	VP & Chief Accounting Officer
Mr. Michael Paulo	VP and Chief Information & Digital Officer
Ms. Yvonne Perron	Vice President of Financial Planning & Analysis and Investor Relations
Mr. John E. O'Brien	Senior Vice President of Corporate Development
Ms. Olga Pirogova	Senior VP & Chief HR Officer
Mr. J. Robert Woodward	Senior Vice President of Global Quality & Regulatory
Dr. Ginger Zhou Ph.D.	Senior VP and GM of the Genewiz Multiomics & Synthesis Solutions

Important FAQs about investing in Azenta from India :

What is Azenta share price today?

Azenta (AZTA) share price today is $45.91.

Can Indians buy Azenta shares?

Yes, Indians can invest in the Azenta (AZTA) from India.

With INDmoney, you can buy Azenta at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Azenta at zero transaction cost.

How can I buy Azenta shares from India?

It is very easy to buy Azenta from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Azenta be purchased?

Yes, you can buy fractional shares of Azenta with INDmoney app.

What are the documents required to start investing in Azenta stocks?

To start investing in Azenta, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.